Form 4: Director Sean Cunningham Receives Maravai Equity Grant
Statement of Changes in Beneficial Ownership
Director Sean Cunningham was awarded 46,293 restricted stock units of Maravai LifeSciences Holdings, Inc. on May 26, 2026.
Summary
- Director Sean Cunningham received an award of 46,293 restricted stock units (RSUs) of Class A Common Stock.
- The grant was issued under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan.
- The RSUs are scheduled to vest in full on the earlier of one year from the grant date or the 2027 annual meeting of stockholders.
- Following this transaction, the reporting person beneficially owns 184,348 shares, held for the benefit of a GTCR-affiliated entity.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified in this filing.
Risks
- Vesting is subject to the terms of the 2020 Omnibus Incentive Plan.
Future Outlook
The RSUs will vest in full on the earlier of May 26, 2027, or the date of the 2027 annual meeting of stockholders.
Industry Context
StockSavvy.ai notes that equity grants to board members are standard corporate governance practice to ensure alignment between directors and shareholders in the life sciences sector.
Comparison to Industry Standards
- The use of restricted stock units for director compensation is consistent with standard practices for publicly traded companies in the biotechnology and life sciences industries.
Related Party Transactions
- The reporting person holds securities for the benefit of a GTCR-affiliated entity and disclaims pecuniary interest.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity incentive grant.
Next Steps
- Vesting of the 46,293 RSUs on the earlier of May 26, 2027, or the 2027 annual meeting.
Key Dates
| Date | Description |
|---|---|
| 05/26/2026 | Date of RSU grant and earliest transaction. |
| 05/28/2026 | Date of filing. |
Keywords
Maravai LifeSciences, MRVI, Form 4, Insider Trading, Equity Compensation, GTCR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.